TY  - JOUR

T1  - Treating active rheumatoid arthritis with Janus kinase inhibitors.

JO  - Lancet

UR  - https://eprints.whiterose.ac.uk/id/eprint/118272

PY  - 2017/06/16

AU  - Scott DL

AU  - Stevenson MD

ED  - 

DO  - DOI: 10.1016/S0140-6736(17)31659-8

PB  - Elsevier

VL  - 390

IS  - 10093

SP  - 431

EP  - 432

Y2  - 2025/11/05

ER  -